Cargando…
New techniques: a roadmap for the development of HCC immunotherapy
Hepatocellular carcinoma (HCC) is one of the most common cancers worldwide. The absence of effective early diagnostic methods and the limitations of conventional therapies have led to a growing interest in immunotherapy as a novel treatment approach for HCC. The liver serves as an immune organ and a...
Autores principales: | Jiang, Dizhi, Ma, Xinyue, Zhang, Xun, Cheng, Bo, Wang, Ruiqing, Liu, Yuan, Zhang, Xinyu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10323423/ https://www.ncbi.nlm.nih.gov/pubmed/37426674 http://dx.doi.org/10.3389/fimmu.2023.1121162 |
Ejemplares similares
-
Advanced HCC Patient Benefit From Neoantigen Reactive T Cells Based Immunotherapy: A Case Report
por: Liu, Chenxi, et al.
Publicado: (2021) -
HBV-Induced Immune Imbalance in the Development of HCC
por: Chen, Yongyan, et al.
Publicado: (2019) -
The Dynamic Role of NK Cells in Liver Cancers: Role in HCC and HBV Associated HCC and Its Therapeutic Implications
por: Sajid, Muhammad, et al.
Publicado: (2022) -
A signature-based classification of lung adenocarcinoma that stratifies tumor immunity
por: Zhang, Xun, et al.
Publicado: (2023) -
INHA acts as a novel and potential biomarker in lung adenocarcinoma and shapes the immune-suppressive tumor microenvironment
por: Zhang, Xun, et al.
Publicado: (2023)